Search Results 171-180 of 18105 for multiple%20sclerosis
Caitlin Doran. August 20, 2019. Research. McArdle's sign, long overlooked, is an indicator of multiple sclerosis. Joel Streed. August 20, 2019. Mayo Clinic ...
Multiple myeloma. Displaying 211 studies. A Study to ... multiple sclerosis (PPMS). The secondare ... 20 patients ≥60 years with relapsed/refractory ...
This motor neuron disease causes nerves within the brain to slowly break down. It causes muscle weakness primarily in the legs, arms and tongue.
A Study to Evaluate the Safety and Effectiveness of SAR442168 Compared to Placebo in Primary Progressive Multiple Sclerosis (PPMS) Patients · Overview.
Mayo Clinic Minute: Exercise modifications help manage multiple sclerosis featured image. Mayo Clinic Minute: Exercise modifications help manage multiple ...
Multiple sclerosis, commonly known as MS, is a potentially disabling disease of the central nervous system. March is Multiple Sclerosis Awareness Month, and ...
The purose of this study is to compare the safety and effectiveness of two different strengths of Rapamycin cream, topical and placebo over 26 weeks in the ...
Park, M.D., Director of the Center for Multiple Sclerosis and Autoimmune Neurology. “We generally use immunosuppressant drugs to prevent attacks in both AQP4 ...
The purpose of this study is to better identify the long term benefit to risk profile of tecfidera in patients with multiple sclerosis who are prescribed ...
Scleroderma (sklair-oh-DUR-muh), also known as systemic sclerosis, is a group of rare diseases that involve the hardening and tightening of the skin.
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your gift to celebrate this day advances our doctors’ lifesaving work.